Non-asthmatic patients show increased exhaled nitric oxide concentrations

Beatriz M Saraiva-Romanholo, Fabio S Machado, Francine M Almeida, Maria do Patrocínio T Nunes, Milton A Martins, Joaquim E Vieira, Beatriz M Saraiva-Romanholo, Fabio S Machado, Francine M Almeida, Maria do Patrocínio T Nunes, Milton A Martins, Joaquim E Vieira

Abstract

Objective: Evaluate whether exhaled nitric oxide may serve as a marker of intraoperative bronchospasm.

Introduction: Intraoperative bronchospasm remains a challenging event during anesthesia. Previous studies in asthmatic patients suggest that exhaled nitric oxide may represent a noninvasive measure of airway inflammation.

Methods: A total of 146,358 anesthesia information forms, which were received during the period from 1999 to 2004, were reviewed. Bronchospasm was registered on 863 forms. From those, three groups were identified: 9 non-asthmatic patients (Bronchospasm group), 12 asthmatics (Asthma group) and 10 subjects with no previous airway disease or symptoms (Control group). All subjects were submitted to exhaled nitric oxide measurements (parts/billion), spirometry and the induced sputum test. The data was compared by ANOVA followed by the Tukey test and Kruskal-Wallis followed by Dunn's test.

Results: The normal lung function test results for the Bronchospasm group were different from those of the asthma group (p <0.05). The median percentage of eosinophils in induced sputum was higher for the Asthma [2.46 (0.45-6.83)] compared with either the Bronchospasm [0.55 (0-1.26)] or the Control group [0.0 (0)] (p <0.05); exhaled nitric oxide followed a similar pattern for the Asthma [81.55 (57.6-86.85)], Bronchospasm [46.2 (42.0 -62.6] and Control group [18.7 (16.0-24.7)] (p< 0.05).

Conclusions: Non-asthmatic patients with intraoperative bronchospasm detected during anesthesia and endotracheal intubation showed increased expired nitric oxide.

Figures

Figure 1-
Figure 1-
Study design
Figure 2-
Figure 2-
Exhaled nitric oxide parts per billion (ENO ppb) measurements from healthy subjects (control) and subjects with history of bronchospasm in intraoperative period (Bronchospasm and Asthma). The boxplot shows the 25th, 50th and 75th percentiles, with the extreme bars representing the 10th and 90th percentiles. ENO (ppb) measure, *p = 0.001 compared with control and **p = 0.005 compared with control.

References

    1. Olsson GL. Bronchospasm during anesthesia. A computer-aided incidence study of 136,929 patients. Acta Anaesthesiol Scand. 1987;31:244–52.
    1. Pizov R, Brown RH, Weiss YS, Baranov D, Hennes H, Baker S, et al. Wheezing during induction of general anesthesia in patients with and without asthma. A randomized, blinded trial. Anesthesiology. 1995;82:1111–16.
    1. Warner DO, Warner MA, Barnes RD, Offord KP, Schroeder DR, Gray DT, et al. Perioperative respiratory complications in patients with asthma. Anesthesiology. 1996;85:460–7.
    1. National Institutes of Health. National Heart, Lung and Blood Institute Global Strategy for Asthma Management and PreventionIssued January, 1995. Updated 2005. []
    1. Silkoff PE, McClean PA, Caramori M, Slutsky AS, Zamel N. A significant proportion of exhaled nitric oxide arises in large airways in normal subjects. Respir Physiol. 1998;113:33–8.
    1. Gaston B, Drazen JM, Loscalzo J, Stamler JS. The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med. 1994;149:538–51.
    1. Prado CM, Leick-Maldonado EA, Kasahara DI, Capelozzi VL, Martins MA, Tiberio IFLC. Effects of acute and chronic nitric oxide inhibition in an experimental model of chronic pulmonary allergic inflammation in guinea pigs. Am J Physiol Lung Cell Mol Physiol. 2005;289:L677–83.
    1. Leme AS, Kasahara DI, Nunes MP, Martins MA, Vieira JE. Exhaled nitric oxide collected with two different mouthpieces: a study in asthmatic patients. Braz J Med Biol Res. 2002;35:1133–7.
    1. Massaro AF, Mehta S, Lilly CM, Kobzik L, Reilly JJ, Drazen JM. Elevated nitric oxide concentrations in isolated lower airway gas of asthmatic subjects. Am J Respir Crit Care Med. 1996;153:1510–14.
    1. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl Med. 2005;352:2163–73.
    1. National Institutes of Health. National Heart, Lung and Blood Institute Global Strategy for Asthma Management and PreventionIssued January, 1995. Updated 2002. NIH Publication. No 02-3659.2002
    1. American Thoracic Society Standardization of spirometry. Am J Respir Crit Care Med. 1995;152:1107–36.
    1. American Thoracic Society Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children. Am J Respir Crit Care Med. 1999;160:2104–17.
    1. Kharitonov S, Alving K, Barnes PJ. Exhaled and nasal nitric oxide measurements: recommendations. Eur Respir J. 1997;10:1683–93.
    1. Pizzichini E, Pizzichini MMM, Efthimiadis A, Hargreave FE, Dolovich J. Measurement of inflammatory indices sputum: effects of selection of sputum to minimize salivary contamination. Eur Respir J. 1996;9:1174–80.
    1. Van Rensen EL, Straathof KC, Veseselic-Charvat MA, Zwinderman AH, Bel EH, Sterk PJ. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils and exhaled nitric oxide levels in patients with asthma. Thorax. 1999;54:403–8.
    1. Saraiva-Romanholo BM, Barnabe V, Carvalho AL, Martins MA, Saldiva PH, Nunes Mdo P. Comparison of three methods for differential cell count in induced sputum. Chest. 2003;124:1060–6.
    1. Winter WE, Hardt NS, Fuhrman S. Immunoglobulin E: importance in parasitic infections and hypersensitivity responses. Arch Pathol Lab Med. 2000;124:1382–5.
    1. Dreborg S. Skin testing. The safety of skin tests and the information obtained from using different methods and concentrations of allergen. Allergy. 1993;48:473–5.
    1. Lima RG, Pastorino AC, Casagrande RR, Sole D, Leone C, Jacob CM. Prevalence of asthma, rhinitis and eczema in 6 - 7 years old students from the western districts of São Paulo City, using the standardized questionnaire of the “International Study of Asthma and Allergies in Childhood” (ISAAC)-phase IIIB. Clinics. 2007;62:225–34.
    1. Van Den Toorn LM, Prins JB, Overbeek SE, Hoogsteden HC, De Jongste JC. Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsivenes. Am J Respir Crit Care Med. 2000;162:953–7.
    1. Kharitonov SA, O’Connor BJ, Evans DJ, Barnes PJ. Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Am J Respir Crit Care Med. 1995;151:1894–99.
    1. Zitt M. Clinical applications of exhaled nitric oxide for the diagnosis and management of asthma: a consensus report. Clin Ther. 2005;27:1238–50.
    1. Lanz MJ, Leung DYM, McCormick DR, Harbeck R, Szefler SJ, White CW. Comparison of exhaled nitric oxide, serum eosinophilic cationic protein, and soluble interleukin-2 receptor in exacerbations of pediatric asthma. Pediatr Pulmonol. 1997;24:305–11.
    1. Barnes PJ, Kharitonov SA. Exhaled nitric oxide: a new lung function test. Thorax. 1996;51:233–7.
    1. Baraldi E, Azzolin NM, Zanconato S, Dario C, Zacchello F. Corticosteroids decrease exhaled nitric oxide in children with acute asthma. J Pediatr. 1997;131:381–5.
    1. Lim S, Jataknaon A, John M, Gilbey T, O’Connor BJ, Chung K, et al. Effect of inhaled budesonide on lung function and airway inflammation: assessment by various inflammatory markers in mild asthma. Am J Respir Crit Care Med. 1999;159:22–30.
    1. Jilma B, Kastner J, Mensik C, Vondrovec B, Hildebrandt J, Krejcy K, et al. Sex differences in concentrations of exhaled nitric oxide and plasma nitrate. Life Sci. 1996;58:469–76.
    1. Gibson PG, Henry RL, Thomas P. Noninvasive assessment of airway inflammation in children: induced sputum, exhaled nitric oxide, and breath condensate. Eur Respir J. 2000;16:1008–15.
    1. Jatakanon A, Lim S, Kharitonov SA, Chung KF, Barnes PJ. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax. 1998;53:91–5.
    1. Berlyne GS, Parameswaran K, Kamada D, Efthimiadis A, Hargreave FE. A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation. J Allergy Clin Immunol. 2000;106:638–44.
    1. Ichinose M, Takahashi T, Sugiura H, Endoh E, Miura M, Mashito Y, et al. Baseline airway hyperresponsiveness and its reversible component: role of airway inflammation and airway calibre. Eur Respir J. 2000;15:248–53.
    1. Nogami H, Shoji S, Nishima S. Exhaled nitric oxide as a simple assessment of airway hyperresponsiveness in bronchial asthma and chronic cough patients. J Asthma. 2003;40:653–9.
    1. Del Giudice MM, Brunese FP, Piacentini GL, Pedulla M, Capristo C, Decimo F, et al. Fractional exhaled nitric oxide (FENO), lung function and airway hyperresponsiveness in naïve atopic asthmatic children. J Asthma. 2004;41:759–65.
    1. Langley SJ, Goldthorpe S, Custovic A, Woodcock A. Relationship among pulmonary function, bronchial reactivity, and exhaled nitric oxide in a large group of asthmatic patients. Ann Allergy Asthma Immunol. 2003;91:398–404.
    1. Spallarossa D, Battistini E, Silvestri M, Sabatini F, Fregonese L, Brazzola G, et al. Steroid-naïve adolescents with mild intermittent allergic asthma have airway hyperresponsiveness and exhaled nitric oxide levels. J Asthma. 2003;40:301–10.
    1. Dupont LJ, Rochette F, Demedts MG, Verleden GM. Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naïve patients with mild asthma. Am J Resp Crit Care Med. 1998;157:894–8.
    1. Crimi E, Spanevello A, Neri M, Ind PW, Rossi GA, Brusasco V. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med. 1998;157:4–9.
    1. Birrell MA, Battram CH, Woodman P, McCluskie K, Belvisi MG.Dissociation by steroids of eosinophilic inflammation from airway hyperresponsiveness in murine airways Respir Res 200343[]

Source: PubMed

3
Abonnieren